Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer

Martin Reck, Tuli De, Luis Paz-Ares,Mark Edmondson-Jones, Yong Yuan, Georgia Yates,Roberto Zoffoli, Mohammad Ashraf Chaudhary,Adam Lee,Nebibe Varol, John R. Penrod

CLINICAL LUNG CANCER（2024）

引用 0|浏览0

暂无评分

关键词

Immunotherapy,NSCLC,Anti-PD-1,Inverse probability of censoring weighting,Checkpoint inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要